FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2573820947> ?p ?o ?g. }

• W2573820947 endingPage "980" @default.
• W2573820947 startingPage "971" @default.
• W2573820947 abstract "Platelets play an active role in the pathogenesis of acute respiratory distress syndrome (ARDS). Animal and observational studies have shown aspirin's antiplatelet and immunomodulatory effects may be beneficial in ARDS.To test the hypothesis that aspirin reduces inflammation in clinically relevant human models that recapitulate pathophysiological mechanisms implicated in the development of ARDS.Healthy volunteers were randomised to receive placebo or aspirin 75 or 1200 mg (1:1:1) for seven days prior to lipopolysaccharide (LPS) inhalation, in a double-blind, placebo-controlled, allocation-concealed study. Bronchoalveolar lavage (BAL) was performed 6 hours after inhaling 50 µg of LPS. The primary outcome measure was BAL IL-8. Secondary outcome measures included markers of alveolar inflammation (BAL neutrophils, cytokines, neutrophil proteases), alveolar epithelial cell injury, systemic inflammation (neutrophils and plasma C-reactive protein (CRP)) and platelet activation (thromboxane B2, TXB2). Human lungs, perfused and ventilated ex vivo (EVLP) were randomised to placebo or 24 mg aspirin and injured with LPS. BAL was carried out 4 hours later. Inflammation was assessed by BAL differential cell counts and histological changes.In the healthy volunteer (n=33) model, data for the aspirin groups were combined. Aspirin did not reduce BAL IL-8. However, aspirin reduced pulmonary neutrophilia and tissue damaging neutrophil proteases (Matrix Metalloproteinase (MMP)-8/-9), reduced BAL concentrations of tumour necrosis factor α and reduced systemic and pulmonary TXB2. There was no difference between high-dose and low-dose aspirin. In the EVLP model, aspirin reduced BAL neutrophilia and alveolar injury as measured by histological damage.These are the first prospective human data indicating that aspirin inhibits pulmonary neutrophilic inflammation, at both low and high doses. Further clinical studies are indicated to assess the role of aspirin in the prevention and treatment of ARDS.NCT01659307 Results." @default.
• W2573820947 created "2017-01-26" @default.
• W2573820947 creator A5006230285 @default.
• W2573820947 creator A5009626082 @default.
• W2573820947 creator A5013535358 @default.
• W2573820947 creator A5014062362 @default.
• W2573820947 creator A5018558613 @default.
• W2573820947 creator A5022040213 @default.
• W2573820947 creator A5023326622 @default.
• W2573820947 creator A5027602652 @default.
• W2573820947 creator A5035957992 @default.
• W2573820947 creator A5040644681 @default.
• W2573820947 creator A5041103166 @default.
• W2573820947 creator A5044994221 @default.
• W2573820947 creator A5051351228 @default.
• W2573820947 creator A5062689783 @default.
• W2573820947 date "2017-01-12" @default.
• W2573820947 modified "2023-10-17" @default.
• W2573820947 title "Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS" @default.
• W2573820947 cites W124753632 @default.
• W2573820947 cites W1600560134 @default.
• W2573820947 cites W1601249330 @default.
• W2573820947 cites W179406719 @default.
• W2573820947 cites W1909429521 @default.
• W2573820947 cites W1986282241 @default.
• W2573820947 cites W1990819855 @default.
• W2573820947 cites W1993384569 @default.
• W2573820947 cites W2009446981 @default.
• W2573820947 cites W2015038971 @default.
• W2573820947 cites W2029844302 @default.
• W2573820947 cites W2032596775 @default.
• W2573820947 cites W2034198619 @default.
• W2573820947 cites W2043132407 @default.
• W2573820947 cites W2063978660 @default.
• W2573820947 cites W2069786094 @default.
• W2573820947 cites W2070824863 @default.
• W2573820947 cites W2085919550 @default.
• W2573820947 cites W2087065938 @default.
• W2573820947 cites W2092616294 @default.
• W2573820947 cites W2098441770 @default.
• W2573820947 cites W2099617023 @default.
• W2573820947 cites W2103010344 @default.
• W2573820947 cites W2104709453 @default.
• W2573820947 cites W2104934425 @default.
• W2573820947 cites W2107833251 @default.
• W2573820947 cites W2121003873 @default.
• W2573820947 cites W2121046729 @default.
• W2573820947 cites W2121827723 @default.
• W2573820947 cites W2124364562 @default.
• W2573820947 cites W2125870353 @default.
• W2573820947 cites W2128349941 @default.
• W2573820947 cites W2129339954 @default.
• W2573820947 cites W2132040583 @default.
• W2573820947 cites W2134887846 @default.
• W2573820947 cites W2136453607 @default.
• W2573820947 cites W2138247049 @default.
• W2573820947 cites W2143152020 @default.
• W2573820947 cites W2149054585 @default.
• W2573820947 cites W2160053026 @default.
• W2573820947 cites W2370339191 @default.
• W2573820947 cites W2620241325 @default.
• W2573820947 cites W4240019765 @default.
• W2573820947 cites W4255637152 @default.
• W2573820947 doi "https://doi.org/10.1136/thoraxjnl-2016-208571" @default.
• W2573820947 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5858553" @default.
• W2573820947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28082531" @default.
• W2573820947 hasPublicationYear "2017" @default.
• W2573820947 type Work @default.
• W2573820947 sameAs 2573820947 @default.
• W2573820947 citedByCount "50" @default.
• W2573820947 countsByYear W25738209472017 @default.
• W2573820947 countsByYear W25738209472018 @default.
• W2573820947 countsByYear W25738209472019 @default.
• W2573820947 countsByYear W25738209472020 @default.
• W2573820947 countsByYear W25738209472021 @default.
• W2573820947 countsByYear W25738209472022 @default.
• W2573820947 countsByYear W25738209472023 @default.
• W2573820947 crossrefType "journal-article" @default.
• W2573820947 hasAuthorship W2573820947A5006230285 @default.
• W2573820947 hasAuthorship W2573820947A5009626082 @default.
• W2573820947 hasAuthorship W2573820947A5013535358 @default.
• W2573820947 hasAuthorship W2573820947A5014062362 @default.
• W2573820947 hasAuthorship W2573820947A5018558613 @default.
• W2573820947 hasAuthorship W2573820947A5022040213 @default.
• W2573820947 hasAuthorship W2573820947A5023326622 @default.
• W2573820947 hasAuthorship W2573820947A5027602652 @default.
• W2573820947 hasAuthorship W2573820947A5035957992 @default.
• W2573820947 hasAuthorship W2573820947A5040644681 @default.
• W2573820947 hasAuthorship W2573820947A5041103166 @default.
• W2573820947 hasAuthorship W2573820947A5044994221 @default.
• W2573820947 hasAuthorship W2573820947A5051351228 @default.
• W2573820947 hasAuthorship W2573820947A5062689783 @default.
• W2573820947 hasBestOaLocation W25738209471 @default.
• W2573820947 hasConcept C126322002 @default.
• W2573820947 hasConcept C203014093 @default.
• W2573820947 hasConcept C2776348555 @default.
• W2573820947 hasConcept C2776914184 @default.
• W2573820947 hasConcept C2777628954 @default.

• next